{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:17:48Z","timestamp":1792279068507,"version":"4.4.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The study assessed the microvascular changes in the retina after the use of 0.125% atropine in children with myopia and the association between retinal microvascular changes and the effects of myopia treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This is a prospective cohort study. Children with myopia aged 5\u201318 years old were included in the study. Retina microvascular parameters were measured with spectral domain optical coherence tomography (OCT) and OCT angiography devices during the follow-up. The main outcome measurements include vessel density of the superficial vascular plexus (SVP), deep vascular plexus, and axial length (AL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 64 eyes of 36 patients were included. A significant decrease in parafoveal vessel density of the SVP was observed in the first 3 months (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.032). The change in parafoveal vessel density of the SVP in the first 3 months correlated negatively with the change in the AL after 1 year (r = \u22120.430,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.028).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These results suggest that 0.125% atropine might induce changes in the retina vasculature in children with myopia and that these changes might correlate with myopia progression. Nevertheless, as a pilot study, this result may need to be confirmed in larger studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo-d-25-00208","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:00:49Z","timestamp":1790179249000},"page":"465-471","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Retinal vasculature changes after 0.125% atropine treatment in children with myopia measured using optical coherence tomography angiography: A pilot study"],"prefix":"10.4103","volume":"16","author":[{"given":"Yao-Chi","family":"Huang","sequence":"first","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Hsin","family":"Chuang","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yeung","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chi","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsien","family":"Tsai","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan"},{"name":"Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chun","family":"Chang","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Chiayi, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Xiamen Branch, Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Fu","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan"},{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan"},{"name":"Program in Molecular Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"R1-20260924","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","article-title":"The epidemics of myopia: Aetiology and prevention","volume":"62","author":"Morgan","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R2-20260924","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"R3-20260924","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.preteyeres.2012.06.004","article-title":"The complex interactions of retinal, optical and environmental factors in myopia aetiology","volume":"31","author":"Flitcroft","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"R4-20260924","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.64.6.7","article-title":"IMI 2023 digest","volume":"64","author":"Sankaridurg","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-20260924","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","article-title":"Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: A 2-year randomised clinical trial","volume":"104","author":"Lam","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R6-20260924","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","article-title":"Spectacle lenses with aspherical lenslets for myopia control versus single-vision spectacle lenses: A randomized clinical trial","volume":"140","author":"Bao","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R7-20260924","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year randomized clinical trial of MiSight lenses for myopia control","volume":"96","author":"Chamberlain","year":"2019","journal-title":"Optom Vis Sci"},{"key":"R8-20260924","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41433-019-0542-8","article-title":"Correlation between pigmented arc and epithelial thickness (COPE) study in orthokeratology-treated patients using OCT measurements","volume":"34","author":"Liu","year":"2020","journal-title":"Eye (Lond)"},{"key":"R9-20260924","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/ICL.0000000000001048","article-title":"Exploring the location of corneal pigmented arc and myopia control efficacy in orthokeratology-treated children using pentacam measurements","volume":"50","author":"Kuo","year":"2024","journal-title":"Eye Contact Lens"},{"key":"R10-20260924","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.clae.2020.02.004","article-title":"Correlation of corneal pigmented arc with wide epithelial thickness map in orthokeratology-treated children using optical coherence tomography measurements","volume":"43","author":"Huang","year":"2020","journal-title":"Cont Lens Anterior Eye"},{"key":"R11-20260924","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/jpm12020278","article-title":"Efficacy of myopia control and distribution of corneal epithelial thickness in children treated with orthokeratology assessed using optical coherence tomography","volume":"12","author":"Kuo","year":"2022","journal-title":"J Pers Med"},{"key":"R12-20260924","doi-asserted-by":"crossref","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI-interventions myopia institute: Interventions for controlling myopia onset and progression report","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-20260924","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: A network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"R14-20260924","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.3390\/jcm12165220","article-title":"Treatment of myopia with atropine 0.125% once every night compared with atropine 0.125% every other night: A pilot study","volume":"12","author":"Chen","year":"2023","journal-title":"J Clin Med"},{"key":"R15-20260924","doi-asserted-by":"crossref","first-page":"e0327354","DOI":"10.1371\/journal.pone.0327354","article-title":"Early identification of the efficacy of 0.125% atropine treatment for children with myopia: A prospective pilot study","volume":"20","author":"Chen","year":"2025","journal-title":"PLoS One"},{"key":"R16-20260924","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"R17-20260924","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: Safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"R18-20260924","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","article-title":"Biological mechanisms of atropine control of myopia","volume":"46","author":"Upadhyay","year":"2020","journal-title":"Eye Contact Lens"},{"key":"R19-20260924","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1111\/bph.15629","article-title":"Insights into the mechanism by which atropine inhibits myopia: Evidence against cholinergic hyperactivity and modulation of dopamine release","volume":"178","author":"Thomson","year":"2021","journal-title":"Br J Pharmacol"},{"key":"R20-20260924","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1021\/pr500558y","article-title":"Involvement of GABA transporters in atropine-treated myopic retina as revealed by iTRAQ quantitative proteomics","volume":"13","author":"Barathi","year":"2014","journal-title":"J Proteome Res"},{"key":"R21-20260924","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2013.02.007","article-title":"An updated view on the role of dopamine in myopia","volume":"114","author":"Feldkaemper","year":"2013","journal-title":"Exp Eye Res"},{"key":"R22-20260924","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.exer.2013.02.017","article-title":"The effects and interactions of GABAergic and dopaminergic agents in the prevention of form deprivation myopia by brief periods of normal vision","volume":"110","author":"Schmid","year":"2013","journal-title":"Exp Eye Res"},{"key":"R23-20260924","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1038\/s41598-025-88025-0","article-title":"Evaluating the effect of 0.125% atropine on foveal microvasculature using optical coherence tomography angiography","volume":"15","author":"Tsai","year":"2025","journal-title":"Sci Rep"},{"key":"R24-20260924","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1167\/iovs.05-0445","article-title":"Peripheral vision can influence eye growth and refractive development in infant monkeys","volume":"46","author":"Smith","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-20260924","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.1167\/iovs.11-7290","article-title":"Change in peripheral refraction over time in Singapore Chinese children","volume":"52","author":"Sng","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20260924","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1167\/iovs.17-21551","article-title":"Axial length variation impacts on superficial retinal vessel density and foveal avascular zone area measurements using optical coherence tomography angiography","volume":"58","author":"Sampson","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R27-20260924","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1167\/iovs.14-14716","article-title":"Analysis of changes in refraction and biometry of atropine- and placebo-treated eyes","volume":"56","author":"Kumaran","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-20260924","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.3390\/jcm9082539","article-title":"Impact of axial eye size on retinal microvasculature density in the macular region","volume":"9","author":"Khan","year":"2020","journal-title":"J Clin Med"},{"key":"R29-20260924","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40123-022-00476-0","article-title":"Short-term effects of atropine 0.01% on the structure and vasculature of the choroid and retina in myopic Chinese children","volume":"11","author":"Wang","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"R30-20260924","doi-asserted-by":"crossref","first-page":"21511","DOI":"10.1038\/s41598-021-96414-4","article-title":"Evaluation of axial length to identify the effects of monocular 0.125% atropine treatment for pediatric anisometropia","volume":"11","author":"Kao","year":"2021","journal-title":"Sci Rep"},{"key":"R31-20260924","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3390\/jcm13102777","article-title":"Myopia is an ischemic eye condition: A review from the perspective of choroidal blood flow","volume":"13","author":"Baksh","year":"2024","journal-title":"J Clin Med"},{"key":"R32-20260924","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2015.04.018","article-title":"Choroidal thickness profiles in myopic eyes of young adults in the correction of myopia evaluation trial cohort","volume":"160","author":"Harb","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R33-20260924","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ajo.2012.07.015","article-title":"The relationship between axial length and choroidal thickness in eyes with high myopia","volume":"155","author":"Flores-Moreno","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R34-20260924","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1167\/iovs.15-16446","article-title":"Longitudinal changes in choroidal thickness and eye growth in childhood","volume":"56","author":"Read","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-20260924","doi-asserted-by":"crossref","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","article-title":"Scleral hypoxia is a target for myopia control","volume":"115","author":"Wu","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-20260924","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuron.2004.08.008","article-title":"Homeostasis of eye growth and the question of myopia","volume":"43","author":"Wallman","year":"2004","journal-title":"Neuron"},{"key":"R37-20260924","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: Phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"key":"R38-20260924","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12886-020-01534-6","article-title":"Seasonal variation in the occurrence of retinal vein occlusion: A 4-year cross-sectional study","volume":"20","author":"Matsuzawa","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R39-20260924","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12886-022-02638-x","article-title":"A moderate dosage of coffee causes acute retinal capillary perfusion decrease in healthy young individuals","volume":"22","author":"Zhu","year":"2022","journal-title":"BMC Ophthalmol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-25-00208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:02:57Z","timestamp":1790254977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-25-00208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-25-00208","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-12-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}